Natus Medical Incorporated today announced that it was awarded, and has shipped, a $1.3 million order for its ALGO hearing screeners from New South Wales, Australia's most populous state. The order was received through the Company's distribution partner working with the local New South Wales government.
“I am also encouraged by the trend of other countries around the world adopting newborn hearing screening programs this year.”
"We are very pleased that New South Wales has upgraded to our latest AABR product, reflecting Australia's commitment to base their newborn hearing screening program exclusively on Natus ALGO products. Our AABR technology is considered to be the gold standard in newborn hearing screening with over 100 published, peer reviewed, clinical studies," said Jim Hawkins, President and Chief Executive Officer of Natus. "I am also encouraged by the trend of other countries around the world adopting newborn hearing screening programs this year."
Research finds particulate pollution during pregnancy may impact newborn kidney function